Smart-C - A phase IIIb open-label, multicentre, international randomised controlled trial of simplified treatment monitoring for 8 weeks glecapevir (300 gm)/pibrentasvis (120mg) in chronic HCV treatment naive patients without cirrhosis.
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
The Kirby Institute
Start Date
February 5, 2018
End Date
December 31, 2019
Administered By
Medicine, Gastroenterology
Awarded By
The Kirby Institute
Start Date
February 5, 2018
End Date
December 31, 2019